华润医药(03320.HK)旗下三款产品获国家药监局药品注册证书

阿斯达克财经
Aug 29, 2025

华润医药(03320.HK) 公布,附属北京万辉双鹤药业、华润双鹤利民药业(济南)和双鹤药业(海南)旗下的氨氯地平贝那普利胶囊、枸橼酸托法替布缓释片及富马酸伏诺拉生片,近日获国家药品监督管理局颁发药品注册证书,视同通过一致性评价。氨氯地平贝那普利胶囊用于治疗高血压,但非初治高血压。枸橼酸托法替布缓释片用于类风湿关节炎、银屑病关节炎及强直性脊柱炎的治疗。富马酸伏诺拉生片适用于反流性食管炎。华润医药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10